Mifepristone Tablet
Product Images NDC 76346-654

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mifepristone (NDC 76346-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Corcept Therapeutics Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mif00 0001 01)

Chemical structure diagram of mifepristone, showing the molecular framework with labeled carbon positions and functional groups including methyl, hydroxyl, and alkyne substituents.*

FDA Label Image

Principal Display Panel (for 280 Tablets Bottle Label (2000012734))

Mifepristone 300 mg tablets label for oral administration shows that each yellow oval-shaped tablet contains 300 mg of mifepristone. The label specifies 280 tablets per container, Rx only, and is manufactured by Corcept Therapeutics Incorporated in Menlo Park, CA. It includes storage instructions, dosage guidance to consult the package insert, and warnings not to split, crush, or chew tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.